Signet Private Wealth »

Outlook Therapeutics shares owned by Signet Private Wealth

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Signet Private Wealth from 13F filings

Historical chart of Signet Private Wealth investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Signet Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Signet Private Wealth

Quarter filed Position value Share count Share price at filing
2026-06-30 $28k 18k 1.59

More positions owned by Signet Private Wealth

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Etf Ser Solutions Defia Quant Etf (QTUM)
Global X Fds S&p 500 Catholic (CATH)
NVIDIA Corporation (NVDA)
Invesco Exch Traded Fd Tr Ii S&p 500 Momntm (SPMO)
Ishares Tr Msci Eafe Etf (EFA)
Spdr Series Trust St Str Blo 1 Etf (BIL)
Alphabet Cap Stk Cl C (GOOG)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Amazon (AMZN)
Applied Materials (AMAT)

View all positions for Signet Private Wealth

Top funds holding Outlook Therapeutics

Vanguard Capital Management
Perceptive Advisors
Marshall Wace
Susquehanna International
BlackRock
Jane Street
Geode Capital Management
Hrt Financial
Vanguard Fiduciary Trust
Gilpin Wealth Management
Citadel Advisors
Sanctuary Advisors
Raymond James Financial
Group One Trading
Northern Trust

View all funds holding Outlook Therapeutics